跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 48 条关于
“Estrella Immunopharma”
全部
48
临床试验
11
药物
6
机构
5
资讯
26
去年
Estrella Immunopharma Advances EB103 ARTEMIS T-Cell Therapy to Second Cohort in STARLIGHT-1 Trial for Advanced B-Cell Lymphomas
上个月
Estrella Immunopharma Doses First Patient in STARLIGHT-1 Dose-Expansion Phase for EB103 ARTEMIS T-Cell Therapy in R/R B-Cell NHL
去年
Estrella's EB103 Cell Therapy Shows Promising Safety Profile in NHL Trial's First Cohort
去年
Estrella Immunopharma's EB103 Shows Complete Response in B-Cell Lymphoma Trial
10个月前
Estrella Immunopharma's EB103 Achieves 100% Complete Response Rate in High-Risk B-Cell Lymphoma Patients
去年
Lyell Immunopharma's IMPT-314 Shows Promise in CAR-T Naive Large B-Cell Lymphoma Patients
去年
Lyell Immunopharma Secures $100 Million Private Placement to Advance CAR T-Cell Therapy Development
去年
Lyell Accelerates IMPT-314 CAR T-Cell Therapy for Large B-Cell Lymphoma
去年
Lyell Immunopharma's IMPT-314 Shows Promise in B-Cell Lymphoma Trial
去年
Lyell Immunopharma's IMPT-314 Shows Promise in Phase 1-2 Trial for Large B-Cell Lymphoma
第 1 页,共 3 页
上一页
下一页